Medtech giants Medtronic and Covidien aren't likely to be very acquisitive after finalizing their $43 billion merger, taking 2 very important players out of the game for startup companies, venture capitalists say.
News Well, On Call, Medtronic buys Covidien, Mergers & Acquisitions, Minnesota, Venture Capital/Private Equity
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/V8LvvS
Cap comentari:
Publica un comentari a l'entrada